9 Analysts Have This to Say About Pliant Therapeutics

Loading...
Loading...

Within the last quarter, Pliant Therapeutics PLRX has observed the following analyst ratings:

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 4 5 0 0 0
Last 30D 1 3 0 0 0
1M Ago 0 0 0 0 0
2M Ago 2 2 0 0 0
3M Ago 1 0 0 0 0

In the last 3 months, 9 analysts have offered 12-month price targets for Pliant Therapeutics. The company has an average price target of $47.11 with a high of $58.00 and a low of $33.00.

Below is a summary of how these 9 analysts rated Pliant Therapeutics over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

This average price target has increased by 8.82% over the past month.

Stay up to date on Pliant Therapeutics analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

What Are Analyst Ratings?

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsBZI-AAR
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...